Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · IEX Real-Time Price · USD
2.520
-0.020 (-0.79%)
May 24, 2024, 4:00 PM EDT - Market closed

Allogene Therapeutics Market Cap

Allogene Therapeutics has a market cap or net worth of $526.14 million as of May 24, 2024. Its market cap has decreased by -40.66% in one year.

Market Cap
526.14M
Enterprise Value
130.98M
1-Year Change
-40.66%
Ranking
Category
Stock Price
$2.52

Market Cap Chart

Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.84B to $526.14M, a decrease of -81.49%. That is a compound annual growth rate of -25.92%.

History

DateMarket Cap% Change
May 24, 2024430.60M-0.78%
May 23, 2024434.00M-4.51%
May 22, 2024454.50M-1.11%
May 21, 2024459.60M3.86%
May 20, 2024442.50M-6.51%
May 17, 2024473.30M-7.97%
May 16, 2024514.30M1.02%
May 15, 2024509.10M0.67%
May 14, 2024505.70M2.06%
May 13, 2024495.50M6.17%
May 10, 2024466.70M-3.49%
May 9, 2024483.60M3.62%
May 8, 2024466.70M-5.16%
May 7, 2024492.10M-3.32%
May 6, 2024509.00M-1.95%
May 3, 2024519.10M3.37%
May 2, 2024502.20M1.72%
May 1, 2024493.70M5.79%
Apr 30, 2024466.70M-2.81%
Apr 29, 2024480.20M-1.74%
Apr 26, 2024488.70M1.22%
Apr 25, 2024482.80M-6.07%
Apr 24, 2024514.00M-9.79%
Apr 23, 2024569.80M-0.89%
Apr 22, 2024574.90M-2.01%
View and export this data all the way back to 2018. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Y-mAbs Therapeutics 530.10M
Heron Therapeutics 524.27M
Altimmune 521.13M
SIGA Technologies 520.97M
OmniAb 518.28M
COMPASS Pathways 512.57M
Pacific Biosciences of California 510.67M
Entrada Therapeutics 509.76M
Market Cap Rankings